Cargando…

PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway

Gastric cancer is a high molecular heterogeneous disease with a poor prognosis. Although gastric cancer is a hot area of medical research, the mechanism of gastric cancer occurrence and development is still unclear. New strategies for treating gastric cancer need to be further explored. Protein tyro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Guan, Bingxin, Liu, Sen, Liu, Haiting, Song, Lin, Zhang, Guohao, Zhao, Ruinan, Zhou, Chengjun, Gao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006225/
https://www.ncbi.nlm.nih.gov/pubmed/36898991
http://dx.doi.org/10.1038/s41419-023-05712-4
_version_ 1784905266385387520
author Li, Hui
Guan, Bingxin
Liu, Sen
Liu, Haiting
Song, Lin
Zhang, Guohao
Zhao, Ruinan
Zhou, Chengjun
Gao, Peng
author_facet Li, Hui
Guan, Bingxin
Liu, Sen
Liu, Haiting
Song, Lin
Zhang, Guohao
Zhao, Ruinan
Zhou, Chengjun
Gao, Peng
author_sort Li, Hui
collection PubMed
description Gastric cancer is a high molecular heterogeneous disease with a poor prognosis. Although gastric cancer is a hot area of medical research, the mechanism of gastric cancer occurrence and development is still unclear. New strategies for treating gastric cancer need to be further explored. Protein tyrosine phosphatases play vital roles in cancer. A growing stream of studies shows that strategies or inhibitors targeting protein tyrosine phosphatases have been developed. PTPN14 belongs to the protein tyrosine phosphatase subfamily. As an inert phosphatase, PTPN14 has very poor activity and mainly functions as a binding protein through its FERM (four-point-one, ezrin, radixin, and moesin) domain or PPxY motif. The online database indicated that PTPN14 may be a poor prognostic factor for gastric cancer. However, the function and underlying mechanism of PTPN14 in gastric cancer remain unclear. We collected gastric cancer tissues and detected the expression of PTPN14. We found that PTPN14 was elevated in gastric cancer. Further correlation analysis indicated that PTPN14 was relevant with the T stage and cTNM (clinical tumor node metastasis classification) stage. The survival curve analysis showed that gastric cancer patients with higher PTPN14 expression had a shorter survival time. In addition, we illustrated that CEBP/β (CCAAT enhanced binding protein beta) could transcriptionally activate PTPN14 expression in gastric cancer. The highly expressed PTPN14 combined with NFkB (nuclear factor Kappa B) through its FERM domain and accelerated NFkB nucleus translocation. Then, NFkB promoted the transcription of PI3KA and initiated the PI3KA/AKT/mTOR pathway to promote gastric cancer cell proliferation, migration, and invasion. Finally, we established mice models to validate the function and the molecular mechanism of PTPN14 in gastric cancer. In summary, our results illustrated the function of PTPN14 in gastric cancer and demonstrated the potential mechanisms. Our findings provide a theoretical basis to better understand the occurrence and development of gastric cancer.
format Online
Article
Text
id pubmed-10006225
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100062252023-03-12 PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway Li, Hui Guan, Bingxin Liu, Sen Liu, Haiting Song, Lin Zhang, Guohao Zhao, Ruinan Zhou, Chengjun Gao, Peng Cell Death Dis Article Gastric cancer is a high molecular heterogeneous disease with a poor prognosis. Although gastric cancer is a hot area of medical research, the mechanism of gastric cancer occurrence and development is still unclear. New strategies for treating gastric cancer need to be further explored. Protein tyrosine phosphatases play vital roles in cancer. A growing stream of studies shows that strategies or inhibitors targeting protein tyrosine phosphatases have been developed. PTPN14 belongs to the protein tyrosine phosphatase subfamily. As an inert phosphatase, PTPN14 has very poor activity and mainly functions as a binding protein through its FERM (four-point-one, ezrin, radixin, and moesin) domain or PPxY motif. The online database indicated that PTPN14 may be a poor prognostic factor for gastric cancer. However, the function and underlying mechanism of PTPN14 in gastric cancer remain unclear. We collected gastric cancer tissues and detected the expression of PTPN14. We found that PTPN14 was elevated in gastric cancer. Further correlation analysis indicated that PTPN14 was relevant with the T stage and cTNM (clinical tumor node metastasis classification) stage. The survival curve analysis showed that gastric cancer patients with higher PTPN14 expression had a shorter survival time. In addition, we illustrated that CEBP/β (CCAAT enhanced binding protein beta) could transcriptionally activate PTPN14 expression in gastric cancer. The highly expressed PTPN14 combined with NFkB (nuclear factor Kappa B) through its FERM domain and accelerated NFkB nucleus translocation. Then, NFkB promoted the transcription of PI3KA and initiated the PI3KA/AKT/mTOR pathway to promote gastric cancer cell proliferation, migration, and invasion. Finally, we established mice models to validate the function and the molecular mechanism of PTPN14 in gastric cancer. In summary, our results illustrated the function of PTPN14 in gastric cancer and demonstrated the potential mechanisms. Our findings provide a theoretical basis to better understand the occurrence and development of gastric cancer. Nature Publishing Group UK 2023-03-10 /pmc/articles/PMC10006225/ /pubmed/36898991 http://dx.doi.org/10.1038/s41419-023-05712-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Li, Hui
Guan, Bingxin
Liu, Sen
Liu, Haiting
Song, Lin
Zhang, Guohao
Zhao, Ruinan
Zhou, Chengjun
Gao, Peng
PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
title PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
title_full PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
title_fullStr PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
title_full_unstemmed PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
title_short PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
title_sort ptpn14 promotes gastric cancer progression by pi3ka/akt/mtor pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006225/
https://www.ncbi.nlm.nih.gov/pubmed/36898991
http://dx.doi.org/10.1038/s41419-023-05712-4
work_keys_str_mv AT lihui ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT guanbingxin ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT liusen ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT liuhaiting ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT songlin ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT zhangguohao ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT zhaoruinan ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT zhouchengjun ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway
AT gaopeng ptpn14promotesgastriccancerprogressionbypi3kaaktmtorpathway